Marc-Antoine Perrissin-Fabert serves as the Vice President of Manufacturing Science & Technology at Ipsen, where he passionately leads a dynamic team dedicated to advancing the pharmaceutical manufacturing landscape. With a robust background in the pharmaceutical industry, Marc-Antoine is adept at navigating the complexities of Good...
Marc-Antoine Perrissin-Fabert serves as the Vice President of Manufacturing Science & Technology at Ipsen, where he passionately leads a dynamic team dedicated to advancing the pharmaceutical manufacturing landscape. With a robust background in the pharmaceutical industry, Marc-Antoine is adept at navigating the complexities of Good Manufacturing Practices (GMP) and ensuring that quality standards are consistently met. His role involves not only overseeing the technical aspects of manufacturing but also fostering a culture of collaboration among cross-functional teams, which is essential for facilitating smooth product supply in an increasingly competitive market.
Under his leadership, key projects focus on process improvement and validation, where he leverages his expertise to enhance operational efficiency and product quality. Marc-Antoine's strategic vision is instrumental in driving innovation within Ipsen's product portfolio, ensuring that the company remains at the forefront of industry advancements. His commitment to knowledge management empowers his team, enabling them to share insights and best practices that contribute to continuous improvement.
Marc-Antoine's ability to coordinate cross-functional initiatives is a testament to his strong leadership skills, as he inspires his team to embrace challenges and deliver exceptional results. By exerting technical leadership and promoting a culture of change control, he not only enhances the manufacturing processes but also aligns them with the broader strategic goals of Ipsen. His passion for manufacturing science and dedication to excellence make him a pivotal figure in the organization, driving both team success and product innovation.